We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Skin Swabs Could Detect Parkinson’s Years Before Symptoms Appear

By LabMedica International staff writers
Posted on 17 Jul 2025

Parkinson’s disease is notoriously difficult to diagnose in its early stages, as motor symptoms do not appear until later in the progression of the disease. More...

The ability to detect the disease up to seven years before symptoms emerge would be transformative, allowing for earlier interventions and improved outcomes. Traditional diagnostic methods do not identify Parkinson’s until physical symptoms manifest, leaving patients at a disadvantage. However, recent research has shown that the chemical composition of skin, specifically the sebum produced by the skin, contains biomarkers that may reveal signs of Parkinson’s disease in its earliest stages. Now, researchers have developed a novel non-invasive sampling method to detect these biomarkers, opening the door to earlier diagnosis of Parkinson’s.

Researchers at The University of Manchester (Manchester, UK) along with collaborators used a technique known as Thermal Desorption-Gas Chromatography-Mass Spectrometry (TD-GC-MS) to analyze skin swabs from participants with Parkinson’s disease, healthy controls, and individuals with isolated REM Sleep Behavior Disorder (iRBD), a condition often seen as an early warning sign of Parkinson’s. By analyzing the chemical profiles of the sebum, they were able to identify distinct biomarkers in individuals with iRBD, who had chemical profiles different from healthy controls but less pronounced than those with Parkinson’s. This technique revealed that Parkinson’s disease leaves a detectable trace on the body long before physical symptoms appear.

The findings of this study, published in the Journal of Parkinson’s Disease, showed that people with iRBD exhibited chemical profiles in their sebum that were distinct from healthy individuals, supporting the idea that Parkinson’s can be detected early. The team also discovered that this non-invasive method could be used to track the progression of Parkinson’s disease, offering the potential for regular monitoring and improved treatment outcomes. The results were validated when a trained "super smeller" was able to distinguish between Parkinson’s and iRBD in skin swabs. The next step in the research is to refine this method to make it a practical tool for clinical use, with further studies aimed at expanding its applications for other diseases.’

“This is the first study to demonstrate a molecular diagnostic method for Parkinson’s disease at the prodromal or early stage,” said Professor Perdita Barran, Professor of Mass Spectrometry at The University of Manchester. “It brings us one step closer to a future where a simple, non-invasive skin swab could help identify people at risk before symptoms arise allowing for earlier intervention and improved outcomes.”

Related Links:
University of Manchester


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Specimen Radiography System
TrueView 200 Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.